Table 3. Maximal aGVHD and cGVHD in... | American Society of Hematology

Table 3.

Maximal aGVHD and cGVHD in pediatric patients receiving Aba GVHD prophylaxis following URD HCT for NMD

Patient ID	Maximum aGVHD	Post-HCT d aGVHD diagnosis	Maximum cGVHD	Post-HCT d cGVHD diagnosis	Post-HCT d off immune suppression	Lansky at 1 y
1	Grade II (stage 3 skin, 1 gut)	24	Moderate (2 skin, 1 mouth)	263	238	80∗
2	N/A	N/A	N/A	N/A	222	100
3	N/A	N/A	N/A	N/A	238	80∗
4	N/A	N/A	N/A	N/A	259	100
5	N/A	N/A	N/A	N/A	159†	NR
6	N/A	N/A	N/A	N/A	174	100
8	Grade II (stage 1 skin)	52	Moderate (2 skin, 1 eyes)	166	298	100
9	Grade II (stage 1 upper GI tract)‡	138	Moderate (2 skin)	299	1322	100
10	N/A	N/A	Moderate (2 skin)	168	294	100

Patient ID	Maximum aGVHD	Post-HCT d aGVHD diagnosis	Maximum cGVHD	Post-HCT d cGVHD diagnosis	Post-HCT d off immune suppression	Lansky at 1 y
1	Grade II (stage 3 skin, 1 gut)	24	Moderate (2 skin, 1 mouth)	263	238	80∗
2	N/A	N/A	N/A	N/A	222	100
3	N/A	N/A	N/A	N/A	238	80∗
4	N/A	N/A	N/A	N/A	259	100
5	N/A	N/A	N/A	N/A	159†	NR
6	N/A	N/A	N/A	N/A	174	100
8	Grade II (stage 1 skin)	52	Moderate (2 skin, 1 eyes)	166	298	100
9	Grade II (stage 1 upper GI tract)‡	138	Moderate (2 skin)	299	1322	100
10	N/A	N/A	Moderate (2 skin)	168	294	100

GI, gastrointestinal.

Baseline score of 80 to 90.

Rapid wean in setting of secondary graft rejection.

Clinical diagnosis only, with negative upper GI tract biopsies.